EMR is not inferior to ESD for early Barrett's and EGJ neoplasia: An extensive review on outcome, recurrence and complication rates.

Endosc Int Open · 2014 · PMC4423274 · PMID 26135261

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP = 0.06so close (0.05 < p ≤ 0.1)

Analysis showed that the recurrence rate was slightly higher in the EMR group (10/380, 2.8 %) compared with the ESD group (1/333, 0.3 %), but the difference did not reach statistical significance (odds ratio 8.55; 95 %CI, 0.91 – 80.0, P = 0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.